CREATININE - ANVISA Registration 80146501905
Access comprehensive regulatory information for CREATININE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501905 and manufactured by ABBOTT POINT OF CARE INC.. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80146501905
25351597290201474
56998701000116
Company Information
Dates and Status
Dec 15, 2014
VIGENTE
09/18/2025 19:00:01
CREATININA
W-Check - Tira de Creatinina
WAMA PRODUTOS PARA LABORATORIO LTDA
10310030247
Jun 16, 2025
CREATININA
Família Creatinina Enzimática
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390305
May 05, 2025
CREATININA
CRE Simplex
TASCOM CO., LTD
80074330008
Jan 06, 2025
CREATININA
CREATININE JAFFE
DAILYTECH LATINO AMERICA LTDA
80657030054
Dec 23, 2024
CREATININA
Família Creatinina Mono
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390265
Oct 07, 2024

